Vicora, Inc.
Buffalo, NY ยท Biotechnology
Vicora, Inc. is a biotechnology company based in Buffalo, New York. In a Form D filed with the SEC on September 18, 2026, it reported raising $2,300,000 from 59 investors as part of an offering of up to $2,500,000. The first sale in the offering took place on April 1, 2026.
- Amount raised
- $2,300,000
- Offering size
- $2,500,000
- Investors so far
- 59
- Minimum investment
- $25,000
- First sale
- April 1, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Buffalo, New York
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $2,300,000 | $2,500,000 | 59 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in New York
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Frictionworx Inc. | Brooklyn, NY | Health Care | $40K | $150K | |
| Atmos Clinic, Inc. | New York, NY | Health Care | $6M | $7M | |
| PreciseDx, Inc. | New York, NY | Health Care | $3.7M | $3.7M | |
| CAD Therapeutics, Inc. | New York, NY | Health Care | $4M | $10M | |
| Click Therapeutics, Inc. | New York, NY | Health Care | $50M | $50M | |
| Amani Therapeutics, Inc. | New York, NY | Health Care | $35M | $60M |